White House Chief of Staff Dr. Anthony Fauci has told U.S. lawmakers that the U.S. National Institutes of Health has funded $ 600,000. the Wuhan Institute of Virology over a period of 5 years to study whether bat coronaviruses can infect humans.
Dr. Fauci appeared before an inquiry committee on Tuesday and revealed that the funds had been channeled into the Chinese research structure through a non-profit company (EcoHealth Alliance), funding a “gentle collaboration with highly respected Chinese scientists who are world-renowned”.
This was stated by the head of the US National Institute of Allergies and Infectious Diseases, but he emphatically denied that the purpose of the research was to handle the coronavirus for any other purpose.
Prior to the confession – “bomb”, as previously everyone denied any US involvement in Uhan fatal laboratory, the director of the National Institutes of Health, Dr. Francis Collins said: “We do not know, of course, about other sources of funding or other activities that may have taken place beyond what our own money allowed.”
The US cut funding to the EcoHealth Alliance last April amid outcry. Dr. Fauci also said that Americans’ interest in bat coronaviruses began when the SARS epidemic broke out nearly two decades ago.
“We were very scared with SARS-CoV-1 in 2002-2003, where this particular virus was undoubtedly transmitted from a bat to an intermediate host, triggering an epidemic and pandemic that resulted in 8,000 cases and close to 800 deaths. “It would be almost a omission of our duties if we did not study this, and the only way to study these things is to go where the action takes place.”
US funding for the Wuhan Institute of Virology has been well under scrutiny in recent years, with voices seeing suspicious relationships proliferate.
The Wall Street Journal revealed over the weekend how three researchers of the fatal institute became so seriously ill in November 2019 that they ended up in the hospital;
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
